Andersons pediatric cardiology 1942

ThromboemboliccomplicationsinFontan
patients:population-basedprevalenceand
explorationoftheetiology.PediatrCardiol.
2013;34:262–272.
129.SeipeltR,FrankeA,Vazquez-JimenezJ,etal.
ThromboemboliccomplicationsafterFontan
procedures:comparisonofdifferenttherapeutic
approaches.AnnThoracSurg.2002;74(2):556–
562.
130.GrewalJ,HusseinM,FeldsteinJ,etal.
EvaluationofsilentthrombusaftertheFontan
operation.CongenitHeartDis.2013;8:40–47.
131.MonagleP,CochraneA,RobertsR,etal.A
multicenter,randomizedtrialcomparing
heparin/warfarinandacetylsalicylicacidas
primarythromboprophylaxisfor2yearsafterthe
Fontanprocedureinchildren.JAmCollCardiol.
2011;58(6):645–651.
132.KaulitzR,ZiemerG,RauchR,etal.Prophylaxis
ofthromboemboliccomplicationsafterthe
Fontanoperation(totalcavopulmonary
anastomosis).JThoracCardiovascSurg.
2005;129:569–575.
133.VarmaC,WarrM,HendlerA,etal.Prevalence
of“Silent”pulmonaryemboliinadultsafterthe
Fontanoperation.JAmCollCardiol.
2003;41:2252–2258.


134.CoonPD,RychikJ,NovelloRT,etal.Thrombus
formationaftertheFontanoperation.Ann

ThoracSurg.2001;71:1990–1994.
135.Robbers-VisserD,MiedemaM,NijveldA,etal.
Resultsofstagedtotalcavopulmonary
connectionforfunctionallyuniventricularhearts;
comparisonofintra-atriallateraltunneland
extracardiacconduit.EurJCardiothoracSurg.
2010;37(4):934–941.
136.KuttyS,RathodRH,DanfordDA,Celermajer
DS.Roleofimagingintheevaluationofsingle
ventriclewiththeFontanpalliation.Heart.
2016;102(3):174–183.
137.AtzAM,TravisonTG,McCrindleBW,etal.
LatestatusofFontanpatientswithpersistent
surgicalfenestration.JAmCollCardiol.
2011;57(24):2437–2443.
138.Cromme-DijkhuisAH,HenkensCM,Bijleveld
CM,etal.Coagulationfactorabnormalitiesas
possiblethromboticriskfactorsafterFontan
operations.Lancet.1990;336(8723):1087–1090.
139.JahangariM,ShoreD,KakkarV,LincolnC,
ShinebourneE.Coagulationfactorabnormalities
aftertheFontanprocedureanditsmodifications.
JThoracCardiovascSurg.1997;113:989–993.
140.OdegardK,McGowanFJr,ZurakowskiD,etal.
Procoagulantandanticoagulantfactor


abnormalitiesfollowingtheFontanprocedure:
increasedfactorVIIImaypredisposeto
thrombosis.JThoracCardiovascSurg.

2003;125:1260–1267.
141.vanNieuwenhuizenR,PetersM,LubbersL,et
al.Abnormalitiesinliverfunctionand
coagulationprofilefollowingtheFontan
procedure.Heart.1999;82(1):40–46.
142.KyrlePA,MinarE,HirschlM,etal.High
plasmalevelsoffactorVIIandtheriskof
recurrentvenousthromboembolsim.NEnglJ
Med.2000;343:457–462.
143.OdegardK,ZurakowskiD,DiNardoJ,etal.
Prospectivelongitudinalstudyofcoagulation
profilesinchildrenwithhypoplasticleftheart
syndromefromstageIthroughFontan
completion.JThoracCardiovascSurg.
2009;137(4):934–941.
144.HollestelleM,ThinnesT,CrainK,etal.Tissue
distributionoffactorVIIIgeneexpressionin
vivo–acloserlook.ThrombHaemost.
2001;86(3):855–861.
145.SomvilleMA,MachielsJ,GillesJG,Saint-Remy
JM.SeasonalvariationinspecificIgEantibodies
ofgrass-pollenhypersensitivepatientsdepends
onthesteadystateIgEconcentrationandisnot
relatedtoclinicalsymptoms.JAllergyClin